Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

3.4K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.4K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.4K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.4K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

3.2K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.2K
Embryonic Stem Cells00:57

Embryonic Stem Cells

4.6K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD38 defines a therapeutically targetable pathogenic T cell population for precision immunotherapy in autoimmune diabetes.

bioRxiv : the preprint server for biology·2026
Same author

Impact of doublet post-transplant maintenance on outcomes in multiple myeloma: A propensity score matching analysis.

Bone marrow transplantation·2026
Same author

Addressing bioenergetic deficits and restoring mitochondrial health in transplanted islets using mesenchymal stem cells.

Stem cells translational medicine·2026
Same author

Multidrug resistance in cancer: current understandings and future perspective.

Molecular biomedicine·2026
Same author

Male-Biased Social Deficits in Chd8<sup>+/R2219*</sup> Mouse Model of Autism Linked to Hippocampal Abnormalities.

Neuroscience bulletin·2026
Same author

Gold decorated bismuth sulfide nanorods for enhanced computed tomography imaging with in vitro and in vivo validation.

Discover nano·2026

Related Experiment Video

Updated: Jan 3, 2026

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
07:03

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Published on: September 23, 2022

2.5K

Stem cell-derived extracellular vesicles: role in oncogenic processes, bioengineering potential, and technical

Mujib Ullah1, Yang Qiao2,3,4,5, Waldo Concepcion2

  • 1Interventional Regenerative Medicine and Imaging Laboratory, Stanford University School of Medicine, Department of Radiology, 3155 Porter Dr., Stanford, CA, 94304, USA. ullah@stanford.edu.

Stem Cell Research & Therapy
|November 28, 2019
PubMed
Summary

Extracellular vesicles (EVs) are key cell communicators, especially when derived from stem cells. Bioengineering these EVs offers promising precision therapeutics for cancer treatment and targeted drug delivery.

Keywords:
CancerExtracellular vesiclesImmunologyInflammationRegenerationRepairStem cellsTransplantation

More Related Videos

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

1.2K
Evaluation of the Storage Stability of Extracellular Vesicles
11:31

Evaluation of the Storage Stability of Extracellular Vesicles

Published on: May 22, 2019

14.9K

Related Experiment Videos

Last Updated: Jan 3, 2026

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
07:03

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Published on: September 23, 2022

2.5K
Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

1.2K
Evaluation of the Storage Stability of Extracellular Vesicles
11:31

Evaluation of the Storage Stability of Extracellular Vesicles

Published on: May 22, 2019

14.9K

Area of Science:

  • Biomedical Engineering
  • Cell Biology
  • Oncology

Background:

  • Extracellular vesicles (EVs) are crucial for intercellular communication, transporting diverse biomolecules like proteins, lipids, and nucleic acids.
  • Stem cell-derived EVs play roles in tissue repair, immune modulation, and cellular processes like proliferation and differentiation.
  • Dysregulation of EVs can disrupt microenvironmental homeostasis, contributing to disease pathogenesis.

Purpose of the Study:

  • To explore the bioengineering potential of EVs for next-generation cancer therapies.
  • To highlight the synergistic roles of stem cells and EVs in tissue repair.
  • To investigate EVs as a platform for targeted drug delivery and cancer treatment.

Main Methods:

  • Review of recent research on EV modification techniques (genetic, biochemical, synthetic).
  • Analysis of EV cargo and their functional implications in cellular communication.
  • Exploration of bioengineering strategies for enhanced EV targeting and therapeutic payload delivery.

Main Results:

  • Stem cell-derived EVs show potential for autocrine and paracrine signaling in tissue repair and regeneration.
  • Engineered EVs can be modified for enhanced targeting of cancer cells and improved drug delivery.
  • EVs offer a versatile platform for developing precision therapeutics by modifying their targeting capabilities.

Conclusions:

  • Bioengineering of EVs presents a novel strategy for cancer therapy by targeting oncogenic processes.
  • Understanding EV modification is key to harnessing their potential for precision therapeutics.
  • EVs are emerging as a powerful tool in bioengineering for advanced drug delivery and cancer treatment.